跳至主要内容
临床试验/NCT06086002
NCT06086002已完成不适用

Evaluation of Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma: A Preliminary Prospective Single Center Study

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年9月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Technical success

研究概览

简要总结

To compare safety and efficacy of microwave ablation with simultaneous ablation using two antennas versus overlapping ablation with single antenna for small hepatocellular carcinoma

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Child-Pugh Class A or B
  • chronic hepatitis B or chronic hepatitis C or liver cirrhosis
  • presence of hepatocellular carcinoma (HCC) confirmed by pathology or imaging studies including contrast enhanced computed tomography (CT) or magnetic resonance imaging (MRI) according to Liver Imaging Reporting and Data System (LI-RADS) v2018
  • single lesion less than or equal to 3 cm, or up to 3 lesions, each greater than less than or equal to 3 cm at the time of locoregional treatment

排除标准

  • number of recurrent HCCs, equal or more than 3
  • largest recurrent HCC size over 3 cm
  • presence of vascular invasion by HCC
  • diffuse infiltrative type HCC
  • HCCs located less than 5 mm from central bile duct or large portal vein or large hepatic vein
  • platelet count less than 40,000 per mm3 or International Normalized Ratio (INR) prolongation over 50%
  • presence of extrahepatic metastasis

研究组 & 干预措施

Overlapping ablation with single antenna

Active Comparator

干预措施: Microwave ablation (Device)

Simultaneous ablation with two antennas

Experimental

干预措施: Microwave ablation (Device)

结局指标

主要结局

Technical success

时间窗: Immediately after ablation

Evaluate technical success defined as complete ablation of the index tumor with safety margin, equal or larger than 5 mm on immediate CT.

Technique efficacy

时间窗: 1 month after ablation

Evaluate technical success defined as complete ablation of the index tumor on 1 month follow-up CT.

Number of Participants with Technical Success

时间窗: Immediately after ablation

Technical success is defined as complete ablation of the index tumor with a safety margin equal to or greater than 5 mm, as confirmed on the computed tomography (CT) scan performed immediately after the ablation procedure.

Number of Participants with Technique Efficacy at 1 Month

时间窗: 1 month after ablation

Technique efficacy is defined as the absence of residual or recurrent tumor at the ablation site (indicating complete ablation), as confirmed on the 1-month follow-up computed tomography (CT) scan.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Min Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular CarcinomaMicrowave AblationLenvatinibRecurrent TumorHepatocellular CarcinomaLiver Cancer
NCT05444478Sun Yat-sen University274
Unknown
不适用
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma HugeHepatocellular Carcinoma Non-resectableTransarterial ChemoembolizationMicrowave Ablation
NCT03277716Fan Weijun100
进行中(未招募)
不适用
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyLung Non-Small Cell CarcinomaMetastatic Colorectal CarcinomaMetastatic SarcomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVB Lung Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8
NCT04430725M.D. Anderson Cancer Center74
Unknown
3 期
Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCCThermal AblationAnlotinibPDL-1Hepatocellular Carcinoma
NCT04665609Chinese PLA General Hospital80
Unknown
不适用
Microwave Venous Ablation in Comparison to Radiofrequency Ablation, Laser Ablation and Surgical Ligation in Management of Great Saphenous Vein IncompetenceVaricose Veins
NCT04479956Mansoura University150